Expression data from docetaxel-resistant prostate cancer cell lines
Docetaxel-based chemotherapy is the standard first-line therapy in metastatic castration-resistant prostate cancer. However, most patients eventually develop resistance to this treatment. The aim of the study was to identify key molecular genes and networks associated with docetaxel resistance in 2 models of docetaxel-resistant castration-resistant prostate cancer cell lines.
Cancer Type: Prostate Cancer
GPL: 570
Number of Genes with Data: 978
Number Observations: 12
Number Outputs: 2
Imbalanced Ratio: 1
Default Task: Classification